Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

College Point, New York Clinical Trials

A listing of College Point, New York clinical trials actively recruiting patient volunteers.

RESULTS

Found (11) clinical trials

People with advanced solid tumors and/or lymphoma are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

4.22 miles

Learn More »

People with non-small cell lung cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

4.32 miles

Learn More »

People with Non-squamous non-small cell lung cancer (NSCLC) or cisplatin-eligible urothelial cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

4.32 miles

Learn More »

A Study of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis

The purpose of this study is to evaluate the safety and efficacy of lebrikizumab compared with placebo in patients with moderate-to-severe atopic dermatitis.

Phase

5.86 miles

Learn More »

Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas

The purpose of this study is to look at the amount of function that returns in participants that have reconstruction with bone graft or artificial device and in participants who have tumor surgery plus regenerative osseous surgery. The study will look at the level of function for a period of ...

Phase N/A

6.01 miles

Learn More »

People with arteriovenous fistula are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

6.25 miles

Learn More »

People with Influenza A are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

6.25 miles

Learn More »

Montefiore Medical Center is seeking patients with major depressive disorder (MDD) between the ages of 18 and 65 to participate in a new depression research study. Dr. Jonathan Alpert is conducting this research to assess if the combination of brexpiprazole and intranasal ketamine can safely and effectively treat depression symptoms ...

Phase

6.25 miles

Learn More »

A Randomized, Double-blind, Placebo-controlled Dose-ranging Study of OPK-88004 Once-a-day Dosing for 16 Weeks in Men with Signs and Symptoms of Benign Prostatic Hyperplasia

Phase

7.52 miles

Learn More »

PRASTERONE (DHEA) FOR THE TREATMENT OF HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) - (PLACEBO-CONTROLLED, DOUBLE-BLIND AND RANDOMIZED PHASE III STUDY OF 24-WEEK INTRAVAGINAL PRASTERONE)

Phase

7.52 miles

Learn More »